Insulet Corporation
PODD

$18.7 B
Marketcap
$266.58
Share price
Country
$4.59
Change (1 day)
$279.40
Year High
$160.19
Year Low
Categories

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

marketcap

Earnings for Insulet Corporation (PODD)

Earnings in 2023 (TTM): $214.6 M

According to Insulet Corporation's latest financial reports the company's current earnings (TTM) are $214.6 M. The earnings displayed on this page is the company's Pretax Income.

Earnings history of Insulet Corporation

Annual Earnings

Year Income Before Tax Net Income
2023 $214.6 M $206.3 M
2022 $9.8 M $4.6 M
2021 $20.5 M $16.8 M
2020 $9.7 M $6.8 M
2019 $14.5 M $11.6 M
2018 $5.23 M $3.29 M
2017 $-26,574,000 $-26,831,000
2016 $-26,818,000 $-28,879,000
2015 $-61,390,000 $-73,520,000
2014 $-51,358,000 $-51,500,000
2013 $-44,874,000 $-44,974,000
2012 $-51,655,000 $-51,867,000
2011 $-57,043,000 $-57,170,000
2010 $-61,159,000 $-61,159,000
2009 $-79,541,000 $-79,541,000
2008 $-92,791,000 $-92,791,000
2007 $-53,539,000 $-53,539,000
2006 $-35,490,000 $-35,950,000
2005 $ $-21,636,000
2004 $ $-13,821,000
2003 $ $-11,941,000
2002 $ $-12,580,000